Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasmaTimothy Devos, Geert Meyfroidt, Quentin Van Thillo et al.|European Respiratory Journal|2021Cited by 49
Mucosal immunization against ovine lentivirus using PEI–DNA complexes and modified vaccinia Ankara encoding the gag and/or env genesRamsés Reina, Gordon D. Harkiss, Cyril Barbezange et al.|Vaccine|2008Cited by 23
Systemic DNA immunization against ovine lentivirus using particle-mediated epidermal delivery and modified vaccinia Ankara encoding the gag and/or env genesH. Niesalla, G.D. Harkiss, X. de Andrés et al.|Vaccine|2008Cited by 22
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trialTimothy Devos, Geert Meyfroidt, Tatjana Geukens et al.|Trials|2020Cited by 19
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022Angela Rose, Patricia Bruijning‐Verhagen, Nathalie Nicolay et al.|Eurosurveillance|2023Cited by 18